The Ozempic revolution has propelled the stock-market value of Danish drugmaker Novo Nordisk above $500 billion for the first time. Tweet on Ozempic Novo Nordisk stock has risen 65% in the past 12Read More
The drugmaker would pay $229 a share in cash for the biotech cancer specialist Pfizer has been looking for acquisitions to help it offset an aging drug lineup. Tweet on Pfizer and SeagenRead More
Merck.inc is aiming to agree on a purchase of the cancer biotech in the next few weeks, according to WSJ, in a deal that could be worth roughly $40 billion. A deal wouldRead More
Evofem Biosciences shares spiked over 240% in the past two days following the overturning of Roe vs. Wade! Evofem Biosciences shares extended their two-day gain over 240% on Monday, and is continuing aRead More
